PEGS Europe 2026

Network with 1,500+ colleagues at the largest protein & antibody engineering event in Europe, which has also been described as “the best biologics technology meeting in Europe.” The 2026 event will feature expanded coverage in ML/AI applications in protein engineering, multispecific antibodies, next generation conjugates, emerging targets, biologics for autoimmune disease, peptide drug discovery, T cell engagers, challenging targets, immunoengineering, oncology, expression, and analytical characterisation.

View the event here.